Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type
Conditions
Brief summary
This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.
Detailed description
PRIMARY OBJECTIVE: I. To perform a retrospective clinicopathologic study on patients diagnosed and treated for clear cell carcinoma of the cervix at M D Anderson Cancer Center (MDACC) and to delineate the immunohistochemical and molecular profile of these cases. OUTLINE: Patients' medical records are reviewed retrospectively, and archival tumor tissue analyzed by immunohistochemistry and next generation sequencing.
Interventions
OTHERElectronic Health Record Review
Medical records reviewed
OTHERLaboratory Biomarker Analysis
Correlative studies
Sponsors
M.D. Anderson Cancer Center
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Healthy volunteers
No
Inclusion criteria
* Patients diagnosed with clear cell carcinoma of the cervix at MDACC
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinicopathologic study on patients diagnosed and treated for clear cell carcinoma of the cervix | through study completion, an average of 1 year |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORAnasis Malpica
M.D. Anderson Cancer Center
Outcome results
None listed